Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Mephedrone alters basal ganglia and limbic dynorphin systems.

Synapse (New York, N.Y.)

German CL, Alburges ME, Hoonakker AJ, Fleckenstein AE, Hanson GR.
PMID: 25155699
Synapse. 2014 Dec;68(12):634-640. doi: 10.1002/syn.21778. Epub 2014 Sep 08.

Mephedrone (4-methymethcathinone) is a synthetic cathinone designer drug that disrupts central nervous system (CNS) dopamine (DA) signaling. Numerous central neuropeptide systems reciprocally interact with dopaminergic neurons to provide regulatory counterbalance, and are altered by aberrant DA activity associated with...

Cite
German CL, Alburges ME, Hoonakker AJ, et al. Mephedrone alters basal ganglia and limbic dynorphin systems. Synapse. 2014;68(12):634-640doi: 10.1002/syn.21778.
German, C. L., Alburges, M. E., Hoonakker, A. J., Fleckenstein, A. E., & Hanson, G. R. (2014). Mephedrone alters basal ganglia and limbic dynorphin systems. Synapse (New York, N.Y.), 68(12), 634-640. https://doi.org/10.1002/syn.21778
German, Christopher L, et al. "Mephedrone alters basal ganglia and limbic dynorphin systems." Synapse (New York, N.Y.) vol. 68,12 (2014): 634-640. doi: https://doi.org/10.1002/syn.21778
German CL, Alburges ME, Hoonakker AJ, Fleckenstein AE, Hanson GR. Mephedrone alters basal ganglia and limbic dynorphin systems. Synapse. 2014 Dec;68(12):634-640. doi: 10.1002/syn.21778. Epub 2014 Sep 08. PMID: 25155699; PMCID: PMC4363041.
Copy Download .nbib Format: NLM
Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate.

Current neuropharmacology

Volz TJ.
PMID: 19587858
Curr Neuropharmacol. 2008 Dec;6(4):379-85. doi: 10.2174/157015908787386041.

Methylphenidate is a psychostimulant that inhibits the neuronal dopamine transporter. In addition, methylphenidate has the intriguing ability to provide neuroprotection from the neurotoxic effects of methamphetamine and perhaps also Parkinson's disease; both of which may likely involve the abnormal...

Cite
Volz TJ. Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. Curr Neuropharmacol. 2008;6(4):379-85doi: 10.2174/157015908787386041.
Volz, T. J. (2008). Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. Current neuropharmacology, 6(4), 379-85. https://doi.org/10.2174/157015908787386041
Volz, T J. "Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate." Current neuropharmacology vol. 6,4 (2008): 379-85. doi: https://doi.org/10.2174/157015908787386041
Volz TJ. Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. Curr Neuropharmacol. 2008 Dec;6(4):379-85. doi: 10.2174/157015908787386041. PMID: 19587858; PMCID: PMC2701286.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries